Asher Biotherapeutics, Inc. is a pioneering biotechnology company based in South San Francisco, CA. They are revolutionizing immunotherapy with their innovative cis-targeted approach, which selectively activates specific immune cell types to achieve optimal therapeutic responses. By addressing the limitations of conventional immunotherapies, Asher Biotherapeutics aims to improve efficacy and minimize side effects for patients.
With their unique platform, Asher Biotherapeutics separates the curves with IL-2, a powerful mediator of the immune system, to develop cis-targeted immunotherapies. Their lead molecule, AB248, has shown promising potential for superior anti-tumor activity compared to other IL-2 targeted therapies. Committed to making a significant impact for patients, Asher Biotherapeutics is dedicated to rapid progress and is seeking talented individuals to join their team.
Generated from the website